Lilly's Cialis wins BPH extension in EU

Lilly's erectile dysfunction drug Cialis (tadalafil) has won EU approval for treating the signs and symptoms of benign prostatic hyperplasia in adult males. It is the only drug in the EU to win approval for the two indications.